Testing effectiveness (Phase 2)Study completedNCT02564718What this trial is testingRivaroxaban for Treatment in Venous or Arterial Thrombosis in NeonatesWho this might be right forThromboembolism Bayer 10
Testing effectiveness (Phase 2)Study completedNCT04945720What this trial is testingHepatic Artery Infusion Chemotherapy (HAIC) Plus Durvalumab for Advanced Hepatocellular CarcinomaWho this might be right forHepatocellular Carcinoma Sun Yat-sen University 30
Post-approval studies (Phase 4)Study completedNCT04367831What this trial is testingIntermediate or Prophylactic-Dose Anticoagulation for Venous or Arterial Thromboembolism in Severe COVID-19Who this might be right forCOVID-19Venous ThrombosesArterial Thrombosis Columbia University 94
Not applicableStudy completedNCT04195113What this trial is testingPerioperative Anticoagulant Use for Surgery Evaluation Emergency RegistryWho this might be right forAtrial FibrillationVenous ThromboembolismArterial Vascular Disease McMaster University 242
Post-approval studies (Phase 4)Study completedNCT02161965What this trial is testingVascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulationWho this might be right forPermanent Atrial FibrillationVenous ThrombosisPulmonary Embolism+1 more University Hospital, Angers 51
Testing effectiveness (Phase 2)Looking for participantsNCT06904183What this trial is testingLenvatinib, Sintilimab, and DEB-TACE With/Without HAIC for HCC >7 cm With PVTTWho this might be right forHepatocellular Carcinoma Non-resectable Second Affiliated Hospital of Guangzhou Medical University 320
Not applicableStudy completedNCT04793100What this trial is testingSpontaneous Retinal Artery Pulses (SPARs) as a Prognostic Determinant of Central Retinal Vein Occlusions (CRVO) in Patients With or Without Intravitreal Aflibercept InjectionsWho this might be right forCentral Retinal Vein Occlusion Fondation Ophtalmologique Adolphe de Rothschild 60
Not applicableLooking for participantsNCT07350499What this trial is testingAspiration Thrombectomy Using the Symphony or Prodigy SystemWho this might be right forArterial ThromboembolismVenous ThromboembolismPulmonary Embolism Imperative Care, Inc. 750
Large-scale testing (Phase 3)Ended earlyNCT01598168What this trial is testingRivaroxaban for Treatment of Patients With Suspected or Confirmed Heparin-Induced ThrombocytopeniaWho this might be right forHeparin-induced Thrombocytopenia McMaster University 22
Testing effectiveness (Phase 2)Looking for participantsNCT07062055What this trial is testingBITS-TO-HCC Study: HAIC+Iparomlimab/Tuvonralimab + Bevacizumab + Surgery/SBRT for BCLC-C HCC With PVTT and/or OligometastasesWho this might be right forHepatocellular CarcinomaPortal Vein Tumor ThrombusOligometastases+3 more Shandong Cancer Hospital and Institute 54
Early research (Phase 1)WithdrawnNCT04580238What this trial is testingOnabotulinum Toxin A (Botox) for the Treatment of Persistent Post-Stroke and Vascular HeadacheWho this might be right forStroke (CVA) or TIAHeadache, MigraineBotulinum Toxins, Type A+5 more University of Alberta
Post-approval studies (Phase 4)Looking for participantsNCT06873321What this trial is testingVTE Incidence After Rivaroxaban + Aspirin or SAPT After Lower-limb RevascularizationWho this might be right forPeripheral Arterial DiseaseVenous ThormboembolismCardiovascular Diseases+1 more Science Valley Research Institute 100
Not applicableUnknownNCT04796740What this trial is testingThrombembolism After Robot- Assisted Surgery in UrologyWho this might be right forUrologic CancerThrombosisEmbolism+1 more University Hospital Schleswig-Holstein 450
Not applicableLooking for participantsNCT06650826What this trial is testingStudy Regarding the Incidence of Anti-platelet Factor 4-antibodies in Patients Aged 18 to 60 Years With Spontaneous or Infection- or Vaccine-associated or Recurrent Venous and/or Arterial ThrombosisWho this might be right forArterial or Venous Thrombosis Cardioangiologisches Centrum Bethanien 200
Early research (Phase 1)Study completedNCT02864810What this trial is testingSafety, Pharmacokinetics, Biodistribution, and Diagnostic Performance of [18F]GP1 PET in ThromboembolismWho this might be right forThromboembolism Asan Foundation 32
Large-scale testing (Phase 3)WithdrawnNCT00238160What this trial is testingSurgery With or Without Hepatic Arterial Chemotherapy in Treating Patients With Liver CancerWho this might be right forLocalized Resectable Adult Primary Liver CancerStage III Childhood Liver Cancer Kyoto University
Not applicableEnrolling By InvitationNCT07814118What this trial is testingMultimodal Physiologic State Intelligence StudyWho this might be right forHeart FailureCardiomyopathiesPulmonary Hypertension+29 more Truway Health, Inc. 25,000
Early research (Phase 1)Study completedNCT01707394What this trial is testingStudy to Evaluate a Single Dose of Apixaban in Pediatric Participants at Risk for a Thrombotic DisorderWho this might be right forThromboembolism Bristol-Myers Squibb 49
Not applicableLooking for participantsNCT07771335What this trial is testingThe Erlanger Stroke Project is an Ongoing Prospective Population-based Stroke Registry in Germany, Including All Hospitalized and Nonhospitalized Patients With Stroke in the City of Erlangen (120.000 Inhabitants).Who this might be right forIntracerebral Haemorrhage (ICH)Cerebral InfarctionCerebral Infarction Due to Thrombosis of Cerebral Arteries+6 more University of Erlangen-Nürnberg Medical School 17,000
Post-approval studies (Phase 4)Study completedNCT02116036What this trial is testingRivaroxaban for Antiphospholipid Antibody SyndromeWho this might be right forAntiphospholipid Antibody Syndrome St. Joseph's Healthcare Hamilton 81